Foti, R.; Amato, G.; Visalli, E.; Bosco, Y.D.; Lucia, F.D.; Montana, A.; Privitera, G.; Romeo, P.; Aiello, F.; Paolì, M.G.;
et al. Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement—Monocentric Real-World Evidence. J. Clin. Med. 2025, 14, 3151.
https://doi.org/10.3390/jcm14093151
AMA Style
Foti R, Amato G, Visalli E, Bosco YD, Lucia FD, Montana A, Privitera G, Romeo P, Aiello F, Paolì MG,
et al. Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement—Monocentric Real-World Evidence. Journal of Clinical Medicine. 2025; 14(9):3151.
https://doi.org/10.3390/jcm14093151
Chicago/Turabian Style
Foti, Roberta, Giorgio Amato, Elisa Visalli, Ylenia Dal Bosco, Francesco De Lucia, Angelo Montana, Giambattista Privitera, Placido Romeo, Fabio Aiello, Maria Gabriella Paolì,
and et al. 2025. "Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement—Monocentric Real-World Evidence" Journal of Clinical Medicine 14, no. 9: 3151.
https://doi.org/10.3390/jcm14093151
APA Style
Foti, R., Amato, G., Visalli, E., Bosco, Y. D., Lucia, F. D., Montana, A., Privitera, G., Romeo, P., Aiello, F., Paolì, M. G., & Foti, R.
(2025). Guselkumab in Psoriatic Arthritis: Therapeutic Impact on Axial and Peripheral Involvement—Monocentric Real-World Evidence. Journal of Clinical Medicine, 14(9), 3151.
https://doi.org/10.3390/jcm14093151
